rs946995680

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_014509.5(SERHL2):​c.147C>A​(p.Asp49Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D49N) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000073 ( 0 hom., cov: 15)
Exomes 𝑓: 0.0000088 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

SERHL2
NM_014509.5 missense

Scores

5
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.25

Publications

0 publications found
Variant links:
Genes affected
SERHL2 (HGNC:29446): (serine hydrolase like 2) Predicted to enable hydrolase activity. Predicted to be located in cytoplasmic vesicle. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.24800533).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SERHL2NM_014509.5 linkc.147C>A p.Asp49Glu missense_variant Exon 2 of 12 ENST00000327678.10 NP_055324.2 Q9H4I8-1A0A140VK89

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SERHL2ENST00000327678.10 linkc.147C>A p.Asp49Glu missense_variant Exon 2 of 12 1 NM_014509.5 ENSP00000331376.5 Q9H4I8-1
SERHL2ENST00000407614.8 linkc.36+111C>A intron_variant Intron 2 of 6 1 ENSP00000385691.4 Q9H4I8-3

Frequencies

GnomAD3 genomes
AF:
0.0000728
AC:
9
AN:
123700
Hom.:
0
Cov.:
15
show subpopulations
Gnomad AFR
AF:
0.000297
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000178
AC:
1
AN:
56182
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.000199
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00000879
AC:
5
AN:
568788
Hom.:
0
Cov.:
7
AF XY:
0.0000101
AC XY:
3
AN XY:
297572
show subpopulations
African (AFR)
AF:
0.000295
AC:
5
AN:
16936
American (AMR)
AF:
0.00
AC:
0
AN:
26512
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
15954
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34504
South Asian (SAS)
AF:
0.00
AC:
0
AN:
55026
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40664
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2264
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
346676
Other (OTH)
AF:
0.00
AC:
0
AN:
30252
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.625
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000727
AC:
9
AN:
123810
Hom.:
0
Cov.:
15
AF XY:
0.0000847
AC XY:
5
AN XY:
59052
show subpopulations
African (AFR)
AF:
0.000295
AC:
9
AN:
30460
American (AMR)
AF:
0.00
AC:
0
AN:
12140
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3170
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4158
South Asian (SAS)
AF:
0.00
AC:
0
AN:
3416
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8734
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
266
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
59184
Other (OTH)
AF:
0.00
AC:
0
AN:
1560
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 18, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.147C>A (p.D49E) alteration is located in exon 2 (coding exon 2) of the SERHL2 gene. This alteration results from a C to A substitution at nucleotide position 147, causing the aspartic acid (D) at amino acid position 49 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.33
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.049
.;T
Eigen
Benign
0.19
Eigen_PC
Benign
0.088
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.80
T;T
M_CAP
Benign
0.021
T
MetaRNN
Benign
0.25
T;T
MetaSVM
Benign
-1.1
T
PhyloP100
2.3
PrimateAI
Uncertain
0.52
T
PROVEAN
Uncertain
-3.0
D;D
REVEL
Benign
0.097
Sift
Uncertain
0.0080
D;D
Sift4G
Benign
0.095
T;T
Polyphen
0.98
.;D
Vest4
0.28
MutPred
0.42
Loss of stability (P = 0.1393);Loss of stability (P = 0.1393);
MVP
0.040
MPC
2.0
ClinPred
0.67
D
GERP RS
1.5
Varity_R
0.25
gMVP
0.32
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs946995680; hg19: chr22-42951068; API